Clinical trials
Completed Lipodystrophy trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 2 |
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 6 |
| 2006 | 6 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 4 |
| 2019 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 59 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 14 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 8 |
| University of Texas Southwestern Medical Center | 6 |
| Massachusetts General Hospital | 4 |
| Glaxo Wellcome | 3 |
| Recros Medica, Inc. | 2 |
| Theratechnologies | 2 |
| Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 1 |
| Aegerion Pharmaceuticals, Inc. | 1 |
| Akcea Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lipodystrophy | 59 |
| HIV Infections | 34 |
| Insulin Resistance | 11 |
| Acquired Immunodeficiency Syndrome | 6 |
| Diabetes Mellitus | 5 |
| Hyperlipidemias | 5 |
| Hypertriglyceridemia | 5 |
| HIV-Associated Lipodystrophy Syndrome | 4 |
| Dyslipidemias | 3 |
| Lipodystrophy, Congenital Generalized | 3 |
Trials
Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.